Trademark: 88200542
Word
DR. MICROBIOME
Status
Dead
Status Code
606
Status Date
Monday, October 18, 2021
Serial Number
88200542
Mark Type
4000
Filing Date
Tuesday, November 20, 2018
Published for Opposition
Tuesday, January 21, 2020
Abandoned Date
Monday, October 18, 2021

Trademark Owner History
NTS Ventures LLC - Owner At Publication

Classifications
5 Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplements, namely, probiotic compositions; nutritional supplements, namely, carbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powder, tablet, liquid, capsule or spray form; mineral supplements in powder, tablet, liquid, capsule or spray form; dietary supplements in powder, tablet, liquid, capsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powder, tablet, liquid, capsule or spray form; herbal supplements for general health and well-being, namely, in powder, tablet, liquid, capsule or spray form; nutritional supplements, namely, probiotic compositions in the nature of a vaginal probiotic for the treatment and prevention of bacterial and fungal vaginal infection; nutraceuticals for the treatment and prevention of bacterial vaginosis, vaginal discharge and odors, for preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odor, killing bacteria that cause bacterial vaginosis, and for maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical use, namely, lactic acid bacteria and bifidobacterial having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Cohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organism cultures, namely, lactic acid bacteria and bifidobacterial having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products, namely, probiotic lactic acid bacteria, probiotic bifidobacterial which are able to ferment and use the fibers in the human organism for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements containing microorganisms and cultures of microorganisms, namely, probiotic lactic acid bacteria, probiotic bifidobacterial which are able to ferment and use the fibers in the human organism; pharmaceutical products for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacterial having probiotic activity on humans for the treatment of diseases, namely, intestinal disorders, diarrhea and to re-equilibrate the intestinal bacterial flora, for the treatment of intestinal inflammations, inflammatory bowel diseases and inflammations of the lower gastrointestinal tract, for the treatment of ulcerative colitis and Crohn's disease in which inflammation is present both in the small intestine and in the colon, and dietary and nutritional supplements for oral consumption, namely, capsules, tablets, solutions, suspensions, granules, and pellets in dried form, containing micro-organisms cultures, namely, lactic acid bacteria and bifidobacterial having probiotic activity on humans; microbial and biological preparations for medical use for improving the physical well-being of humans, namely, reducing inflammation and pain; dietary supplements for medical use, and baby food, all the above containing preparations and products resulting from the processing of microorganisms, particularly metabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal and bacterial probiotic supplements, and nutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's Disease, ulcerative colitis and irritable bowel syndrome; beverages containing probiotic compositions for use as a nutritional and dietary supplement; food products containing probiotic compositions for use as a nutritional and dietary supplement; human food products containing probiotic compositions for use as a nutritional and dietary supplement; animal food products containing probiotic compositions for use as a nutritional and dietary supplement; probiotic compositions in the form of mixes for use as a nutritional and dietary supplement to be added to beverages and food products
9 Downloadable electronic publications, namely, articles and papers in the field of human microbiota related to the digestive system and colon; downloadable electronic publications, namely, scientific analysis and informational reports based upon results of laboratory testing in the field of the digestive system
41 Providing online, non-downloadable articles, blogs and papers in the field of human microbiota and human microbiome, probiotics, human wellness, digestive system conditions and diseases, colon conditions and diseases, genetic conditions, genetic conditions related to the digestive system, genetic conditions related to the colon, human diet, dietary supplements, vitamin and nutrient supplements; providing on-line, non-downloadable publications in the nature of articles, blogs and papers in the field of human microbiota and human microbiome, probiotics, human wellness, digestive system conditions and diseases, colon conditions and diseases, genetic conditions, genetic conditions related to the digestive system, genetic conditions related to the colon, human diet, dietary supplements, vitamin and nutrient supplements; providing online, non-downloadable publications in the nature of scientific analysis and informational reports based upon results of laboratory testing in the field of human microbiota and human microbiome, probiotics, human wellness, digestive system conditions and diseases, colon conditions and diseases, genetic conditions, genetic conditions related to the digestive system, genetic conditions related to the colon, human diet, dietary supplements, vitamin and nutrient supplements; providing an online resource center featuring online, non-downloadable articles, blogs and papers in the field of human microbiota related to the digestive system; providing on-line, non-downloadable publications in the nature of articles, blogs and papers in the field of human microbiota related to the digestive system
43 Providing a website featuring information in the field of recipes and cooking for others for foods that include probiotics, vitamins and nutrients

Trademark Events
Oct 18, 2021
Abandonment Notice E-Mailed - No Use Statement Filed
Oct 18, 2021
Abandonment - No Use Statement Filed
Mar 19, 2021
Notice Of Approval Of Extension Request E-Mailed
Mar 17, 2021
Extension 2 Granted
Mar 17, 2021
Extension 2 Filed
Mar 17, 2021
Teas Extension Received
Oct 5, 2020
Applicant/Correspondence Changes (Non-Responsive) Entered
Oct 5, 2020
Teas Change Of Correspondence Received
Oct 5, 2020
Attorney/Dom.Rep.Revoked And/Or Appointed
Oct 5, 2020
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Oct 5, 2020
Teas Change Of Owner Address Received
Sep 19, 2020
Notice Of Approval Of Extension Request E-Mailed
Sep 17, 2020
Extension 1 Granted
Sep 17, 2020
Extension 1 Filed
Sep 17, 2020
Teas Extension Received
Mar 17, 2020
Noa E-Mailed - Sou Required From Applicant
Jan 21, 2020
Official Gazette Publication Confirmation E-Mailed
Jan 21, 2020
Published For Opposition
Jan 1, 2020
Notification Of Notice Of Publication E-Mailed
Dec 19, 2019
Law Office Publication Review Completed
Dec 11, 2019
Assigned To Lie
Dec 9, 2019
Approved For Pub - Principal Register
Dec 9, 2019
Examiner's Amendment Entered
Dec 9, 2019
Notification Of Examiners Amendment E-Mailed
Dec 9, 2019
Examiners Amendment E-Mailed
Dec 9, 2019
Examiners Amendment -Written
Dec 9, 2019
Previous Allowance Count Withdrawn
Oct 15, 2019
Withdrawn From Pub - Og Review Query
Oct 1, 2019
Approved For Pub - Principal Register
Sep 24, 2019
Teas/Email Correspondence Entered
Sep 24, 2019
Correspondence Received In Law Office
Sep 24, 2019
Teas Request For Reconsideration Received
Sep 16, 2019
Notification Of Final Refusal Emailed
Sep 16, 2019
Final Refusal E-Mailed
Sep 16, 2019
Final Refusal Written
Aug 6, 2019
Teas/Email Correspondence Entered
Aug 6, 2019
Correspondence Received In Law Office
Aug 6, 2019
Teas Response To Office Action Received
Feb 7, 2019
Notification Of Non-Final Action E-Mailed
Feb 7, 2019
Non-Final Action E-Mailed
Feb 7, 2019
Non-Final Action Written
Feb 7, 2019
Notification Of Non-Final Action E-Mailed
Feb 7, 2019
Non-Final Action E-Mailed
Feb 7, 2019
Non-Final Action Written
Jan 31, 2019
Assigned To Examiner
Dec 8, 2018
New Application Office Supplied Data Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24